These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24936676)

  • 1. Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers.
    Abdou AG; Elwahed MG; Serag El-Dien MM; Eldien DS
    Am J Dermatopathol; 2014 Dec; 36(12):959-64. PubMed ID: 24936676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
    Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
    Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
    Seleit I; Bakry OA; Samaka RM; Malak MA
    Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
    Batinac T; Zamolo G; Jonjić N; Gruber F; Petrovecki M
    Tumori; 2004; 90(1):120-7. PubMed ID: 15143984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
    El-Hawary AK; Yassin E; Khater A; Abdelgaber S
    Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
    Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
    Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of STAT3 phosphorylation and p53 expression on human epidermal non melanoma cutaneous tumors].
    Cai SQ; Chen LR; Wang HJ; Yao LF; Zheng M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):331-4. PubMed ID: 15269985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
    Gaballah MA; Ahmed RA
    Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
    Huang K; Huang C; Shan K; Chen J; Li H
    Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
    Mihailovici MS; Teleman S; Ungureanu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical assessment of endothelin-1 axis in psoriasis, basal cell carcinoma and squamous cell carcinoma.
    Salem SA; Gamal Aly D; Salah Youssef N; Moneim El-Shaer MA
    G Ital Dermatol Venereol; 2015 Jun; 150(3):283-91. PubMed ID: 25946671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased level of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinoma.
    Ahmed NU; Ueda M; Ichihashi M
    Br J Dermatol; 1997 Jun; 136(6):908-12. PubMed ID: 9217824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
    Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of a novel beta 1 integrin in normal and pathologic squamous epithelia.
    Cerri A; Favre A; Giunta M; Corte G; Grossi CE; Berti E
    J Invest Dermatol; 1994 Feb; 102(2):247-52. PubMed ID: 7508965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A; Kanellou P; Spandidos DA
    Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
    Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
    Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.